Aviso: Este site agrega dados públicos oficiais da FDA, ClinicalTrials.gov, PubMed e SEC EDGAR apenas para referência geral. Não constitui aconselhamento médico, diagnóstico, recomendação de tratamento ou aconselhamento de investimento.

PubMed

Photobiomodulation therapy for androgenetic alopecia: A clinician's guide to home-use devices cleared by the Federal Drug Administration.

PMID: 29020478 ·

E, r, i, n, , M, , D, o, d, d, ;, , M, a, r, g, o, , A, , W, i, n, t, e, r, ;, , M, a, r, i, a, , K, , H, o, r, d, i, n, s, k, y, ;, , N, e, i, l, , S, , S, a, d, i, c, k, ;, , R, o, n, d, a, , S, , F, a, r, a, h

RevistaJournal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology
Ano
PMID29020478

Resumo

The market for home-use photobiomodulation devices to treat androgenetic alopecia has rapidly expanded, and the Food and Drug Administration (FDA) has recently cleared many devices for this purpose. Patients increasingly seek the advice of dermatologists regarding the safety and efficacy of these hair loss treatments. The purpose of this guide was threefold: (1) to identify all home-use photobiomodulation therapy devices with FDA-clearance for treatment of androgenetic alopecia; (2) to review de

Fonte oficial

Ver no PubMed →

Dados provenientes do PubMed / NCBI. Para consultar o texto integral e as informações mais recentes, recorra sempre ao registo oficial.

↑